U.S. flag

An official website of the United States government

NM_174878.3(CLRN1):c.189C>A (p.Tyr63Ter) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 7, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001384937.4

Allele description [Variation Report for NM_174878.3(CLRN1):c.189C>A (p.Tyr63Ter)]

NM_174878.3(CLRN1):c.189C>A (p.Tyr63Ter)

Gene:
CLRN1:clarin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q25.1
Genomic location:
Preferred name:
NM_174878.3(CLRN1):c.189C>A (p.Tyr63Ter)
HGVS:
  • NC_000003.12:g.150972520G>T
  • NG_009168.1:g.5480C>A
  • NM_001195794.1:c.189C>A
  • NM_001256819.2:c.189C>A
  • NM_174878.3:c.189C>AMANE SELECT
  • NP_001182723.1:p.Tyr63Ter
  • NP_001243748.1:p.Tyr63Ter
  • NP_777367.1:p.Tyr63Ter
  • LRG_700t1:c.189C>A
  • LRG_700:g.5480C>A
  • LRG_700p1:p.Tyr63Ter
  • NC_000003.11:g.150690307G>T
  • NM_174878.3:c.189C>A
  • NR_046380.3:n.208C>A
  • c.189C>A
  • p.Tyr63X
Protein change:
Y63*; TYR63TER
Links:
OMIM: 606397.0006; dbSNP: rs111033267
NCBI 1000 Genomes Browser:
rs111033267
Molecular consequence:
  • NR_046380.3:n.208C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001195794.1:c.189C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001256819.2:c.189C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_174878.3:c.189C>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001584632Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 7, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3.

Joensuu T, Hämäläinen R, Yuan B, Johnson C, Tegelberg S, Gasparini P, Zelante L, Pirvola U, Pakarinen L, Lehesjoki AE, de la Chapelle A, Sankila EM.

Am J Hum Genet. 2001 Oct;69(4):673-84. Epub 2001 Aug 27. Erratum in: Am J Hum Genet 2001 Nov;69(5):1160.

PubMed [citation]
PMID:
11524702
PMCID:
PMC1226054

Experience of targeted Usher exome sequencing as a clinical test.

Besnard T, García-García G, Baux D, Vaché C, Faugère V, Larrieu L, Léonard S, Millan JM, Malcolm S, Claustres M, Roux AF.

Mol Genet Genomic Med. 2014 Jan;2(1):30-43. doi: 10.1002/mgg3.25. Epub 2013 Jul 10.

PubMed [citation]
PMID:
24498627
PMCID:
PMC3907913
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV001584632.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change creates a premature translational stop signal (p.Tyr63*) in the CLRN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLRN1 are known to be pathogenic (PMID: 11524702, 24498627). This variant is present in population databases (rs111033267, gnomAD 0.008%). This premature translational stop signal has been observed in individuals with Usher syndrome (PMID: 12080385, 23304067). ClinVar contains an entry for this variant (Variation ID: 4397). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 17, 2024